Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Tyrosine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.52 |
| ▸ | ITGA4 | P13612 | 8/20 | 0.42 |
| ▸ | ITGB1 | P05556 | 3/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.39 |
| ▸ | ALPI | P09923 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | XIAP | P98170 | 1/20 | 0.39 |
| ▸ | DPP4 | P27487 | 2/20 | 0.39 |
| ▸ | PCNA | P12004 | 1/20 | 0.38 |
| ▸ | CTSC | P53634 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.38 |
| ▸ | LCK | P06239 | 1/20 | 0.38 |
| ▸ | FYN | P06241 | 1/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tyrosine SCHEMBL6665573 | 0.97 | SLC7A5 (0.56) | SLC7A5ITGA4ITGB1PTGS1ALPI | |
| Tyrosine SCHEMBL4205061 | 0.92 | SLC7A5 (0.61) | SLC7A5ITGA4ITGB1PTGS1ALPI | |
| Tyrosine SCHEMBL4205059 | 0.92 | SLC7A5 (0.61) | SLC7A5ITGA4ITGB1PTGS1ALPI | |
| Tyrosine SCHEMBL4352800 | 0.92 | SLC7A5 (0.61) | SLC7A5ITGA4ITGB1PTGS1ALPI | |
| Tyrosine SCHEMBL5152642 | 0.92 | SLC7A5 (0.61) | SLC7A5ITGA4ITGB1PTGS1ALPI | |
| Phenylalanine SCHEMBL1828216 | 0.91 | SLC7A5 (0.50) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL999871 | 0.89 | SLC7A5 (0.52) | SLC7A5ITGA4ITGB1PTGS1ALPI | |
| Tyrosine SCHEMBL2205278 | 0.89 | SLC7A5 (0.52) | SLC7A5ITGA4ITGB1PTGS1ALPI | |
| Tyrosine SCHEMBL28209802 | 0.89 | SLC7A5 (0.52) | SLC7A5ITGA4ITGB1PTGS1ALPI | |
| Tyrosine SCHEMBL28603345 | 0.89 | SLC7A5 (0.52) | SLC7A5ITGA4ITGB1PTGS1ALPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170226155-A1 | Smart Pro-Drugs of Serine Protease Inhibitors | TRUSTEES OF TUFTS COLLEGE (US) | 2017-08-10 | — | — | US | disclosed |
| US-9629921-B2 | Smart pro-drugs of serine protease inhibitors | TRUSTEES OF TUFTS COLLEGE (US) | 2017-04-25 | — | — | US | disclosed |
| US-20130303435-A1 | Smart Pro-Drugs of Serine Protease Inhibitors | BACH BIOSCIENCES, LLC | 2013-11-14 | — | — | US | disclosed |
| EP-2319523-A1 | Serine protease inhibitors | Trustees Of Tufts College (US) | 2011-05-11 | — | — | EP | disclosed |
| EP-2204181-A2 | Protease inhibitors | Trustees of Tufts College (US) | 2010-07-07 | — | — | EP | disclosed |
| US-20100168032-A1 | Smart Pro-Drugs of Serine Protease Inhibitors | TRUSTEES OF TUFTS COLLEGE (US) | 2010-07-01 | — | — | US | disclosed |
| US-7691967-B2 | Smart pro-drugs of serine protease inhibitors | TRUSTEES OF TUFTS COLLEGE (US) | 2010-04-06 | — | — | US | disclosed |
| US-20060089312-A1 | Protease inhibitors | BACH BIOSCIENCES, LLC | 2006-04-27 | — | — | US | disclosed |
| EP-1499336-A4 | PROTEASE INHIBITORS | TUFTS COLLEGE (US) | 2005-06-01 | — | — | EP | disclosed |
| EP-1499336-A2 | PROTEASE INHIBITORS | Trustees of Tufts College (US) | 2005-01-26 | — | — | EP | disclosed |
| WO-2003092605-A9 | PROTEASE INHIBITORS | TUFTS COLLEGE (US) | 2004-04-08 | — | — | WO | disclosed |
| WO-2003092605-A2 | PROTEASE INHIBITORS | TRUSTEES OF TUFTS COLLEGE (US) | 2003-11-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130303435-A1 | Smart Pro-Drugs of Serine Protease Inhibitors | FAP, PREP, CTSC | SLC7A5 2558/4885ITGA4 3133/4885ITGB1 3315/4885 |
| US-20170226155-A1 | Smart Pro-Drugs of Serine Protease Inhibitors | FAP, PREP, CTSC | SLC7A5 2558/4885ITGA4 3133/4885ITGB1 3315/4885 |
| US-20060089312-A1 | Protease inhibitors | FAP, PREP, TFPI | SLC7A5 3719/4885ITGA4 3333/4885ITGB1 3619/4885 |
| US-20100168032-A1 | Smart Pro-Drugs of Serine Protease Inhibitors | FAP, PREP, CTSC | SLC7A5 2558/4885ITGA4 3133/4885ITGB1 3315/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.